Thymidine
AlkaPlorer ID: AK001124
Synonym: None
IUPAC Name: 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Structure
SMILES: CC1=CN([C@H]2C[C@H](O)[C@@H](CO)O2)C(=O)NC1=O
InChI: InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1
InChIKey: IQFYYKKMVGJFEH-XLPZGREQSA-N
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|---|---|---|---|---|---|---|
| Biemna ehrenbergi | Biemna | Biemnidae | Biemnida | Demospongiae | Porifera | Metazoa | Eukaryota |
Properties Information
Molecule Weight: 242.231
TPSA?: 104.54999999999998
MolLogP?: -1.5142799999999992
Number of H-Donors: 3
Number of H-Acceptors: 6
RingCount: 2
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Artemia | Artemia | LC50 | 1000.0 | ppm | 10.1021/np50122a023 |
| Chlorocebus sabaeus | Vero | Activity | nan | None | 10.1016/j.bmc.2008.04.045 |
| Chlorocebus sabaeus | Vero | IC50 | 0.3 | nM | 10.1021/jm981132u |
| Chlorocebus sabaeus | Vero | IC50 | 0.4 | nM | 10.1021/jm981132u |
| Drosophila melanogaster | Deoxynucleoside kinase | Activity | 60000.0 | microM/min/mg | 10.1016/j.bmcl.2009.12.097 |
| Enterococcus faecium | Enterococcus faecium | ED50 | 11.0 | uM | 10.1021/jm00209a010 |
| Escherichia coli K-12 | Thymidine phosphorylase | Activity | 0.0 | % | 10.1016/j.bmc.2008.01.038 |
| Escherichia coli K-12 | Thymidine phosphorylase | Activity | 82.0 | % | 10.1016/j.bmc.2008.01.038 |
| Escherichia coli K-12 | Thymidine phosphorylase | Activity | 86.0 | % | 10.1016/j.bmc.2008.01.038 |
| Escherichia coli K-12 | Thymidine phosphorylase | k cat | 1770.0 | s-1 | 10.1021/jm049494r |
| Escherichia coli K-12 | Thymidine phosphorylase | Kcat | 1770.0 | /s | 10.1016/j.ejmech.2007.07.015 |
| Escherichia coli K-12 | Thymidine phosphorylase | Km | 240000.0 | nM | 10.1016/j.ejmech.2007.07.015 |
| Escherichia coli K-12 | Thymidine phosphorylase | Km | 240000.0 | nM | 10.1021/jm049494r |
| Escherichia coli K-12 | Thymidine phosphorylase | Km | 2500000.0 | nM | 10.1016/j.bmc.2008.01.038 |
| Escherichia coli K-12 | Thymidine phosphorylase | Phosphorolysis | 72.0 | % | 10.1021/jm00051a006 |
| Escherichia coli K-12 | Thymidine phosphorylase | Ratio | 7400000.0 | 1/Ms | 10.1021/jm049494r |
| Escherichia coli K-12 | Thymidine phosphorylase | Vmax | 1.15 | mM/min | 10.1021/jm049494r |
| Escherichia coli K-12 | Thymidine phosphorylase | Vmax | 5.2 | mM/min | 10.1016/j.bmc.2008.01.038 |
| Hepatitis B virus | Hepatitis B virus | EC50 | 300.0 | nM | 10.1128/aac.00001-07 |
| Hepatitis B virus | Hepatitis B virus | Inhibition | 0.0 | % | 10.1016/j.bmcl.2010.08.120 |
| Hepatitis B virus | Hepatitis B virus | Inhibition | nan | % | 10.1016/j.bmcl.2010.08.120 |
| Homo sapiens | 143B | CC50 | 600000.0 | nM | 10.1021/jm030544m |
| Homo sapiens | 143B | CC50 | 700000.0 | nM | 10.1021/jm030544m |
| Homo sapiens | ATH-8 cell line | ED50 | 100.0 | uM | 10.1021/jm00391a003 |
| Homo sapiens | ATH-8 cell line | ID50 | 100.0 | uM | 10.1021/jm00391a003 |
| Homo sapiens | ATPase family AAA domain-containing protein 2 | Kd | 10000000.0 | nM | 10.1039/C4MD00237G |
| Homo sapiens | CCRF-CEM | Activity | 10.0 | % | 10.1021/jm040144e |
| Homo sapiens | CCRF-CEM | Activity | 18.0 | % | 10.1021/jm058234m |
| Homo sapiens | CCRF-CEM | Activity | 20.0 | % | 10.1021/jm058234m |
| Homo sapiens | CCRF-CEM | Activity | 40.0 | % | 10.1021/jm040144e |
| Homo sapiens | CCRF-CEM | Activity | 92.0 | % | 10.1021/jm040144e |
| Homo sapiens | CCRF-CEM | Activity | 96.0 | % | 10.1021/jm040144e |
| Homo sapiens | CCRF-CEM | CC50 | 10600.0 | nM | 10.1021/acs.jmedchem.0c00358 |
| Homo sapiens | CFPAC-1 | Activity | 0.0 | % | 10.1021/jm8005965 |
| Homo sapiens | DNA-(apurinic or apyrimidinic site) lyase | Potency | 8912.5 | nM | None |
| Homo sapiens | DNA cross-link repair 1A protein | IC50 | nan | None | 10.1016/j.bmc.2021.116369 |
| Homo sapiens | DNA cross-link repair 1A protein | Inhibition | nan | % | 10.1016/j.bmc.2021.116369 |
| Homo sapiens | HEL | MCC | 250000.0 | nM | 10.1016/j.bmcl.2018.09.019 |
| Homo sapiens | HeLa | IC50 | 4000000.0 | nM | 10.1016/j.bmcl.2004.10.039 |
| Homo sapiens | HepG2 | CC50 | 2100000.0 | nM | 10.1128/aac.00001-07 |
| Homo sapiens | HL-60 | CC50 | 1760000.0 | nM | 10.1128/aac.00001-07 |
| Homo sapiens | HL-60 | ID50 | 0.61 | uM | 10.1021/jm00403a026 |
| Homo sapiens | HL-60 | ID50 | 336.0 | uM | 10.1021/jm00403a026 |
| Homo sapiens | HL-60 | ID50 | 461.0 | uM | 10.1021/jm00403a026 |
| Homo sapiens | HL-60 | ID50 | 901.0 | uM | 10.1021/jm00403a026 |
| Homo sapiens | MT4 | Protection | 10.0 | % | 10.1021/jm00391a003 |
| Homo sapiens | MT4 | Protection | 40.0 | % | 10.1021/jm00391a003 |
| Homo sapiens | MT4 | Toxicity | 10.0 | % | 10.1021/jm00391a003 |
| Homo sapiens | Solute carrier family 22 member 1 | Activity | nan | None | 10.1124/mol.51.6.913 |
| Homo sapiens | Thymidine kinase, cytosolic | Activity | nan | None | 10.1021/jm00100a029 |
| Homo sapiens | Thymidine kinase, cytosolic | IC50 | 16.0 | nM | 10.1021/jm011128+ |
| Homo sapiens | Thymidine kinase, cytosolic | IC50 | 26.0 | nM | 10.1021/jm011128+ |
| Homo sapiens | Thymidine kinase, cytosolic | IC50 | 1800.0 | nM | 10.1021/jm011128+ |
| Homo sapiens | Thymidine kinase, cytosolic | IC50 | 500000.0 | nM | 10.1021/jm011128+ |
| Homo sapiens | Thymidine kinase, cytosolic | ID50 | 2.0 | uM | 10.1021/jm00100a029 |
| Homo sapiens | Thymidine kinase, cytosolic | Inhibition | nan | % | 10.1021/jm021108n |
| Homo sapiens | Thymidine kinase, cytosolic | k cat | 0.35 | s-1 | 10.1021/jm030241s |
| Homo sapiens | Thymidine kinase, cytosolic | Ki | 200.0 | nM | 10.1021/jm030241s |
| Homo sapiens | Thymidine kinase, cytosolic | Ki | 2000.0 | nM | 10.1021/jm00100a029 |
| Homo sapiens | Thymidine kinase, cytosolic | Kinase activity | 174.0 | pM min-1*ml-1 | 10.1021/jm00088a015 |
| Homo sapiens | Thymidine kinase, cytosolic | Kinase activity | 585.0 | pM min-1*ml-1 | 10.1021/jm00088a015 |
| Homo sapiens | Thymidine kinase, cytosolic | Km | 290.0 | nM | 10.1021/jm00388a021 |
| Homo sapiens | Thymidine kinase, cytosolic | Km | 660.0 | nM | 10.1021/jm00388a021 |
| Homo sapiens | Thymidine kinase, cytosolic | Km | 1000.0 | nM | 10.1021/jm010216r |
| Homo sapiens | Thymidine kinase, cytosolic | Km | 1800.0 | nM | 10.1016/j.bmc.2010.03.023 |
| Homo sapiens | Thymidine kinase, cytosolic | Km | 2800.0 | nM | 10.1021/jm00100a029 |
| Homo sapiens | Thymidine kinase, cytosolic | Km | 3000.0 | nM | 10.1021/jm00163a043 |
| Homo sapiens | Thymidine kinase, cytosolic | Km | 4000.0 | nM | 10.1021/jm00163a043 |
| Homo sapiens | Thymidine kinase, cytosolic | Km | 49000.0 | nM | 10.1021/jm060404n |
| Homo sapiens | Thymidine kinase, cytosolic | Rate of phosphorylation | 1.0 | None | 10.1021/jm020047q |
| Homo sapiens | Thymidine kinase, cytosolic | Ratio | 439.0 | /min.mg | 10.1016/j.bmc.2010.03.023 |
| Homo sapiens | Thymidine kinase, cytosolic | Relative velocity | 6.0 | % | 10.1021/jm00394a039 |
| Homo sapiens | Thymidine kinase, cytosolic | Relative velocity | 100.0 | % | 10.1021/jm00394a039 |
| Homo sapiens | Thymidine kinase, cytosolic | Relative Vmax | 1.0 | None | 10.1021/jm010216r |
| Homo sapiens | Thymidine kinase, cytosolic | Relative Vmax | 100.0 | None | 10.1021/jm010216r |
| Homo sapiens | Thymidine kinase, cytosolic | Vmax | 790.0 | nmol/mg.min | 10.1016/j.bmc.2010.03.023 |
| Homo sapiens | Thymidine phosphorylase | Km | 187000.0 | nM | 10.1021/jm00182a029 |
| Homo sapiens | Thymidylate kinase | Ki | 180000.0 | nM | 10.1016/j.bmc.2008.04.045 |
| Homo sapiens | Thymidylate kinase | Ki | 180000.0 | nM | 10.1021/jm040847w |
| Human adenovirus 2 | Human adenovirus 2 | EC50 | 22000.0 | nM | 10.1016/j.bmcl.2018.09.019 |
| Human alphaherpesvirus 1 | Human alphaherpesvirus 1 | ED50 | 1000.0 | uM | 10.1021/jm00403a026 |
| Human alphaherpesvirus 1 | Human alphaherpesvirus 1 | ID50 | nan | None | 10.1021/jm00381a015 |
| Human alphaherpesvirus 2 | Human alphaherpesvirus 2 | ED50 | 1000.0 | uM | 10.1021/jm00403a026 |
| Human herpesvirus 1 | Thymidine kinase | Km | 1000.0 | nM | 10.1128/aac.01284-06 |
| Human herpesvirus 1 | Thymidine kinase | Relative velocity | 100.0 | % | 10.1021/jm00394a039 |
| Human herpesvirus 1 | Thymidine kinase | Vmax | 17.0 | nmol/hr/microg | 10.1128/aac.01284-06 |
| Human herpesvirus 1 (strain SC16) (HHV-1) (Human herpes simplex virus1) | Thymidine kinase | IC50 | 1000.0 | nM | 10.1021/jm960278v |
| Human herpesvirus 1 (strain SC16) (HHV-1) (Human herpes simplex virus1) | Thymidine kinase | Km | 810.0 | nM | 10.1021/jm00388a021 |
| Human herpesvirus 1 (strain SC16) (HHV-1) (Human herpes simplex virus1) | Thymidine kinase | Relative velocity | 100.0 | % | 10.1021/jm00394a039 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | 3470.0 | nM | 10.1021/acs.jmedchem.0c00358 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | 4110.0 | nM | 10.1021/acs.jmedchem.0c00358 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | 10000.0 | nM | 10.1021/acs.jmedchem.0c00358 |
| Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | EC50 | 40000.0 | nM | 10.1021/jm00010a008 |
| Human immunodeficiency virus 2 | Human immunodeficiency virus 2 | EC50 | 40000.0 | nM | 10.1021/jm00010a008 |
| Macacine herpesvirus 1 | Thymidine kinase | Activity | 100.0 | % | 10.1128/aac.01284-06 |
| Macacine herpesvirus 1 | Thymidine kinase | Activity | 130.0 | % | 10.1128/aac.01284-06 |
| Macacine herpesvirus 1 | Thymidine kinase | IC50 | 4100.0 | nM | 10.1128/aac.01284-06 |
| Macacine herpesvirus 1 | Thymidine kinase | Km | 650.0 | nM | 10.1128/aac.01284-06 |
| Macacine herpesvirus 1 | Thymidine kinase | Km | 700.0 | nM | 10.1128/aac.01284-06 |
| Macacine herpesvirus 1 | Thymidine kinase | Ratio | 0.23 | None | 10.1128/aac.01284-06 |
| Macacine herpesvirus 1 | Thymidine kinase | Ratio | 0.28 | None | 10.1128/aac.01284-06 |
| Macacine herpesvirus 1 | Thymidine kinase | Vmax | 0.15 | nmol/hr/microg | 10.1128/aac.01284-06 |
| Macacine herpesvirus 1 | Thymidine kinase | Vmax | 0.2 | nmol/hr/microg | 10.1128/aac.01284-06 |
| Mus musculus | KBALB cell line | CC50 | 95000.0 | nM | 10.1021/jm020299r |
| Mus musculus | KBALB cell line | CC50 | 970000.0 | nM | 10.1021/jm030544m |
| Mus musculus | L1210 | Concentration | 0.0001 | M | 10.1021/jm00382a006 |
| Mus musculus | L1210 | Concentration | 0.0002 | M | 10.1021/jm00382a006 |
| Mus musculus | L1210 | ID50 | 6.3 | ug ml-1 | 10.1021/jm00359a008 |
| Mus musculus | L929 | Incorporation rate | 465.0 | c.p.m. hr-1 | 10.1021/jm00155a033 |
| Mus musculus | L929 | Incorporation rate | 2937.0 | c.p.m. hr-1 | 10.1021/jm00155a033 |
| Mus musculus | L929 | Incorporation rate | 28200.0 | c.p.m. hr-1 | 10.1021/jm00155a033 |
| Mus musculus | L929 | Phosphorylation rate | 100.0 | uM | 10.1021/jm0491896 |
| Mus musculus | LM | Activity | 53.0 | None | 10.1021/jm00378a036 |
| Mus musculus | LM | Activity | 2276.0 | None | 10.1021/jm00378a036 |
| Mus musculus | LM | Incorporation rate | 185.0 | c.p.m. hr-1 | 10.1021/jm00155a033 |
| Mus musculus | LM | Incorporation rate | 204.0 | c.p.m. hr-1 | 10.1021/jm00155a033 |
| Mus musculus | LM | Incorporation rate | 213.0 | c.p.m. hr-1 | 10.1021/jm00155a033 |
| Mus musculus | LM | Incorporation rate | 228.0 | c.p.m. hr-1 | 10.1021/jm00155a033 |
| Mus musculus | LM | Incorporation rate | 251.0 | c.p.m. hr-1 | 10.1021/jm00155a033 |
| Mus musculus | LM | Inhibition | 98.5 | % | 10.1021/jm00378a036 |
| Mus musculus | MC-38 | Activity | nan | None | 10.1021/np060462b |
| Mus musculus | Mus musculus | Activity | 25.5 | % | 10.1021/np50122a023 |
| Mus musculus | Mus musculus | Ki | 0.09 | None | 10.1021/jm00387a015 |
| Mus musculus | Mus musculus | Ki | 80000.0 | nM | 10.1021/jm00126a024 |
| Mus musculus | Thymidine kinase, cytosolic | Relative phosphorylation | 1.0 | None | 10.1021/jm990125i |
| Mus musculus | Thymidylate synthase | ID50 | 75.0 | uM | 10.1021/jm00403a026 |
| Mycobacterium tuberculosis | Mycobacterium tuberculosis | Activity | nan | None | 10.1016/j.bmc.2008.04.045 |
| Mycobacterium tuberculosis | Thymidylate kinase | Ki | 27000.0 | nM | 10.1016/j.bmc.2008.04.045 |
| Mycobacterium tuberculosis | Thymidylate kinase | Ki | 27000.0 | nM | 10.1016/s0960-894x(03)00643-7 |
| Mycobacterium tuberculosis | Thymidylate kinase | Ki | 27000.0 | nM | 10.1021/jm021108n |
| Mycobacterium tuberculosis | Thymidylate kinase | Ki | 27000.0 | nM | 10.1021/jm040847w |
| Mycobacterium tuberculosis | Thymidylate kinase | Ki | 27000.0 | nM | 10.1021/jm0492296 |
| Mycobacterium tuberculosis | Thymidylate kinase | Ki | 27000.0 | nM | None |
| Mycobacterium tuberculosis | Thymidylate kinase | Ki | 715000.0 | nM | 10.1016/s0960-894x(03)00643-7 |
| Rattus norvegicus | Peripheral myelin protein 22 | Potency | 18105.6 | nM | None |
| Rattus norvegicus | Thymidine kinase | Km | 1600.0 | nM | 10.1021/jm00349a007 |
| Rattus norvegicus | Thymidine kinase | Km | 8000.0 | nM | 10.1021/jm00349a007 |
| Rattus norvegicus | Thymidine kinase | Phosphorylation rate | 100.0 | uM | 10.1021/jm0491896 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 4.84 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 19952.62 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 20000.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.09 | % | 10.6019/CHEMBL4495565 |
| Staphylococcus aureus | Thymidine kinase | Kcat | 0.44 | /s | 10.1128/aac.00081-07 |
| Staphylococcus aureus | Thymidine kinase | Kcat/Km | 1.6 | 10'5/M/s | 10.1128/aac.00081-07 |
| Staphylococcus aureus | Thymidine kinase | Ki | 257000.0 | nM | 10.1128/aac.00081-07 |
| Staphylococcus aureus | Thymidine kinase | Km | 2800.0 | nM | 10.1128/aac.00081-07 |
| Staphylococcus aureus | Thymidine kinase | Vmax | 1.2 | U/mg | 10.1128/aac.00081-07 |
| Ureaplasma parvum serovar 3 (strain ATCC 700970) | Thymidine kinase | Km | 1900.0 | nM | 10.1016/j.bmc.2010.03.023 |
| Ureaplasma parvum serovar 3 (strain ATCC 700970) | Thymidine kinase | Ratio | 637.0 | /min.mg | 10.1016/j.bmc.2010.03.023 |
| Ureaplasma parvum serovar 3 (strain ATCC 700970) | Thymidine kinase | Vmax | 1210.0 | nmol/mg.min | 10.1016/j.bmc.2010.03.023 |
| Vaccinia virus (strain Western Reserve) (VACV) (Vaccinia virus (strainWR)) | Thymidine kinase | Km | 21000.0 | nM | 10.1128/aac.01447-06 |
| Vaccinia virus (strain Western Reserve) (VACV) (Vaccinia virus (strainWR)) | Thymidine kinase | Ratio | 15.0 | None | 10.1128/aac.01447-06 |
| Vaccinia virus (strain Western Reserve) (VACV) (Vaccinia virus (strainWR)) | Thymidine kinase | Vmax | 302.0 | microM/min/mg | 10.1128/aac.01447-06 |
| None | ADMET | Activity | nan | None | 10.1021/np060462b |
| None | ADMET | CC50 | 200.0 | ug.mL-1 | 10.1016/j.bmcl.2010.08.120 |
| None | ADMET | IZ | 0.0 | mm | 10.1021/np060462b |
| None | ADMET | k cat | 0.35 | s-1 | 10.1021/jm030241s |
| None | ADMET | Km | 1000.0 | nM | 10.1021/jm990125i |
| None | ADMET | Retention time | 8.72 | min | 10.1021/jm0491896 |
| None | Hepatotoxicity | HepSE_bilirubinemia | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cholecystitis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cholelithiasis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_cirrhosis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_Combined Scores | 1.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_elevated liver function tests | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatic failure | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatic necrosis | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatitis | 1.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_hepatomegaly | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_jaundice | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver disease | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver fatty | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | Hepatotoxicity | HepSE_liver function tests abnormal | 0.0 | None | 10.1371/journal.pcbi.1002310 |
| None | KBALB-STK | CC50 | 100000.0 | nM | 10.1021/jm020299r |
| None | KBALB-STK | CC50 | 650000.0 | nM | 10.1021/jm030544m |
| None | NON-PROTEIN TARGET | CC50 | 130000.0 | nM | 10.1021/jm020299r |
| None | No relevant target | P | 0.055 | None | 10.1021/jm00163a043 |
| None | No relevant target | P | 0.06 | None | 10.1021/jm00051a006 |
| None | No relevant target | pKa | 9.8 | None | 10.1021/jm00209a010 |
| None | PRK | ID50 | 0.25 | ug ml-1 | 10.1021/jm00359a008 |
| None | PRK | ID50 | 0.3 | ug ml-1 | 10.1021/jm00359a008 |
| None | PRK | ID50 | 10.0 | ug ml-1 | 10.1021/jm00359a008 |
| None | PRK | ID50 | 200.0 | ug ml-1 | 10.1021/jm00359a008 |
| None | PRK | ID50 | 300.0 | ug ml-1 | 10.1021/jm00359a008 |
| None | Unchecked | Activity | nan | None | 10.1021/acs.jnatprod.5b00987 |
| None | Unchecked | Delta Tm | 0.2 | None | 10.1016/0960-894X(95)00050-4 |
| None | Unchecked | Delta Tm | 0.25 | None | 10.1016/0960-894X(95)00050-4 |
| None | Unchecked | Delta Tm | 0.3 | None | 10.1016/0960-894X(95)00050-4 |
| None | Unchecked | Delta Tm | 0.4 | None | 10.1016/0960-894X(95)00050-4 |
| None | Unchecked | Delta Tm | 2.5 | None | 10.1016/0960-894X(95)00050-4 |
| None | Unchecked | Ki | 200.0 | nM | 10.1021/jm030241s |
| None | Unchecked | Ki | 2800.0 | nM | 10.1021/jm00196a025 |
| None | Unchecked | Km | 23000.0 | nM | 10.1128/aac.01447-06 |
| None | Unchecked | Ratio | 14.5 | None | 10.1128/aac.01447-06 |
| None | Unchecked | Ratio | nan | None | 10.1021/jm021108n |
| None | Unchecked | Ratio Ki | 6.6 | None | 10.1021/jm040847w |
| None | Unchecked | Ratio Ki | 7.0 | None | 10.1016/j.bmc.2008.04.045 |
| None | Unchecked | Vmax | 1.0 | uM min-1 | 10.1021/jm00182a029 |
| None | Unchecked | Vmax | 334.0 | microM/min/mg | 10.1128/aac.01447-06 |
